Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Flamel Technologies SA (NASDAQ:FLML)

9.35
Delayed Data
As of Feb 05
 -0.16 / -1.68%
Today’s Change
9.08
Today|||52-Week Range
26.09
-23.42%
Year-to-Date
No recent news for Flamel Technologies SA.

Today’s Trading

Previous close9.51
Today’s open9.41
Day’s range9.08 - 9.50
Volume109,749
Average volume (3 months)313,053
Market cap$378.7M
Dividend yield--
Data as of 3:59pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-36.26%
Earnings growth (this year)+66.75%
Earnings growth (next 5 years)+31.00%
Revenue growth (last year)-35.21%
P/E ratioNM
Price/Sales42.64
Price/Book15.56

Competitors

 Today’s
change
Today’s
% change
ARNAArena Pharmaceutical...-0.04-2.48%
TRVNTrevena Inc+0.16+2.17%
VNDAVanda Pharmaceutical...-0.17-1.93%
CORTCorcept Therapeutics...-0.16-4.51%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 9, 2016
EPS forecast (this quarter)$0.12
Annual revenue (last year)$14.6M
Annual profit (last year)-$83.6M
Net profit margin-601.85%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Michael Shannon Anderson
Chief Financial Officer &
Senior Vice President
Michael F. Kanan
Corporate headquarters
Vénissieux, Rhone-alpes

Forecasts

Partner Offers